P
EXAS

&Partners’s Exact Sciences EXAS Stock Holding History

&Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,757
Closed -$1.9M – 2423
2025
Q4 		$1.9M Buy
18,757
+239
+1% +$19.2K 0.01% 892
2025
Q3 		$1.01M Buy
18,518
+3,046
+20% +$152K 0.01% 1080
2025
Q2 		$821K Buy
+15,472
New +$786K 0.01% 1082

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

&Partners's EXAS Position: Q1 2026 in Review

&Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 18,757 shares — an estimated $1.9M sold.

&Partners first reported a position in EXAS in Q2 2025 and held it in 3 quarters. The position peaked at $1.9M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • &Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • &Partners sold 18,757 Exact Sciences shares in Q1 2026, an estimated $1.9M.
  • &Partners first reported a position in Exact Sciences in Q2 2025 and held it in 3 quarters.
  • &Partners's Exact Sciences position peaked at $1.9M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.